Safety and feasibility of a lower dose intravenous TPA therapy for ischemic stroke beyond the first three hours Academic Article uri icon

Overview

MeSH Major

  • Brain Ischemia
  • Fibrinolytic Agents
  • Stroke
  • Thrombolytic Therapy
  • Tissue Plasminogen Activator

abstract

  • Lower dose i.v. TPA in patients presenting beyond 3 h carries a risk of intracerebral hemorrhage. However, recanalization with dramatic recovery can still occur.

publication date

  • May 11, 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1159/000084090

PubMed ID

  • 15731557

Additional Document Info

start page

  • 260

end page

  • 6

volume

  • 19

number

  • 4